NCT06804850 2025-11-19
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC
West China Hospital
Phase 2 Withdrawn
West China Hospital
Brooklyn ImmunoTherapeutics, LLC
Institut de cancérologie Strasbourg Europe
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of California, San Diego
University Hospital Center of Martinique